Jeffrey C. Barrett

Jeffrey C. Barrett

Auto-generated profile, based on publicly available information

Jeffrey C. Barrett

Nightingale Health

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2013 in Nature
Verified
Journal Article
Open access
PDF file
KHKerstin Howe
Kerstin Howe
MCMatthew D. Clark
Matthew D. Clark
CTCarlos F. Torroja
Carlos F. Torroja
JTJames Torrance
James Torrance
CBCamille Berthelot
Camille Berthelot
DSDerek L. Stemple
Derek L. Stemple
A high-quality sequence assembly of the zebrafish genome reveals the largest gene set of any vertebrate and provides information on key genomic features, and comparison to the human reference genome shows that approximately 70% of human protein-coding genes have at least one clear zebrafish orthologue. The genome of the zebrafish — a key model organism for the study of development and human disease — has now been sequenced and published as a well-annotated reference genome. Zebrafish turns out to have the largest gene set of any vertebrate so far sequenced, and few pseudogenes. Importantly for disease studies, comparison between human and zebrafish sequences reveals that 70% of human genes have at least one obvious zebrafish orthologue. A second paper reports on an ongoing effort to identify and phenotype disruptive mutations in every zebrafish protein-coding gene. Using the reference genome sequence along with high-throughput sequencing and efficient chemical mutagenesis, the project's initial results — covering 38% of all known protein-coding genes — they describe phenotypic consequences of more than 1,000 alleles. The long-term goal is the creation of a knockout allele in every protein-coding gene in the zebrafish genome. All mutant alleles and data are freely available at go.nature.com/en6mos . Zebrafish have become a popular organism for the study of vertebrate gene function1,2. The virtually transparent embryos of this species, and the ability to accelerate genetic studies by gene knockdown or overexpression, have led to the widespread use of zebrafish in the detailed investigation of vertebrate gene function and increasingly, the study of human genetic disease3,4,5. However, for effective modelling of human genetic disease it is important to understand the extent to which zebrafish genes and gene structures are related to orthologous human genes. To examine this, we generated a high-quality sequence assembly of the zebrafish genome, made up of an overlapping set of completely sequenced large-insert clones that were ordered and oriented using a high-resolution high-density meiotic map. Detailed automatic and manual annotation provides evidence of more than 26,000 protein-coding genes6, the largest gene set of any vertebrate so far sequenced. Comparison to the human reference genome shows that approximately 70% of human genes have at least one obvious zebrafish orthologue. In addition, the high quality of this genome assembly provides a clearer understanding of key genomic features such as a unique repeat content, a scarcity of pseudogenes, an enrichment of zebrafish-specific genes on chromosome 4 and chromosomal regions that influence sex determination.

31 October 2012 in Nature
Verified
Journal Article
Open access
PDF file
T(The International IBD Genetics Consortium (IIBDGC)
The International IBD Genetics Consortium (IIBDGC)
LJLuke Jostins
Luke Jostins
SRStephan Ripke
Stephan Ripke
RWRinse K. Weersma
Rinse K. Weersma
RDRichard H. Duerr
Richard H. Duerr
JCJudy H Cho
Judy H Cho
A meta-analysis of previous genome-wide association studies of Crohn’s disease and ulcerative colitis, the two most common forms of inflammatory bowel disease, with a combined total of more than 75,000 cases and controls, finds that most loci contribute to both phenotypes and other immune-mediated disorders. Genetic studies have implicated unsuspected mechanisms in the pathogenesis of Crohn's disease and ulcerative colitis, two of the most common forms of inflammatory bowel disease. This paper presents a meta-analysis of published genome-wide association studies, together with validation in more than 75,000 cases and controls. In addition to several new associations, the authors find that most loci contribute to both phenotypes, but also to other immune-mediated disorders. The data reveal an overlap between susceptibility loci for inflammatory bowel disease and mycobacterial infection, and between the pathways that govern host responses to mycobacteria and those predisposing to inflammatory bowel disease. Crohn’s disease and ulcerative colitis, the two common forms of inflammatory bowel disease (IBD), affect over 2.5 million people of European ancestry, with rising prevalence in other populations1. Genome-wide association studies and subsequent meta-analyses of these two diseases2,3 as separate phenotypes have implicated previously unsuspected mechanisms, such as autophagy4, in their pathogenesis and showed that some IBD loci are shared with other inflammatory diseases5. Here we expand on the knowledge of relevant pathways by undertaking a meta-analysis of Crohn’s disease and ulcerative colitis genome-wide association scans, followed by extensive validation of significant findings, with a combined total of more than 75,000 cases and controls. We identify 71 new associations, for a total of 163 IBD loci, that meet genome-wide significance thresholds. Most loci contribute to both phenotypes, and both directional (consistently favouring one allele over the course of human history) and balancing (favouring the retention of both alleles within populations) selection effects are evident. Many IBD loci are also implicated in other immune-mediated disorders, most notably with ankylosing spondylitis and psoriasis. We also observe considerable overlap between susceptibility loci for IBD and mycobacterial infection. Gene co-expression network analysis emphasizes this relationship, with pathways shared between host responses to mycobacteria and those predisposing to IBD.

11 May 2007 in Science
Verified
Journal Article
Closed access
TFTimothy M. Frayling
Timothy M. Frayling
NTNicholas J. Timpson
Nicholas J. Timpson
MWMichael N. Weedon
Michael N. Weedon
EZEleftheria Zeggini
Eleftheria Zeggini
RFRachel M. Freathy
Rachel M. Freathy
MMMark I. McCarthy
Mark I. McCarthy
Obesity is a serious international health problem that increases the risk of several common diseases. The genetic factors predisposing to obesity are poorly understood. A genome-wide search for type 2 diabetes–susceptibility genes identified a common variant in the FTO (fat mass and obesity associated) gene that predisposes to diabetes through an effect on body mass index (BMI). An additive association of the variant with BMI was replicated in 13 cohorts with 38,759 participants. The 16% of adults who are homozygous for the risk allele weighed about 3 kilograms more and had 1.67-fold increased odds of obesity when compared with those not inheriting a risk allele. This association was observed from age 7 years upward and reflects a specific increase in fat mass.

20 July 2015 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JLJimmy Z Liu
Jimmy Z Liu
SSSuzanne van Sommeren
Suzanne van Sommeren
HHHailiang Huang
Hailiang Huang
SNSiew C Ng
Siew C Ng
RARudi Alberts
Rudi Alberts
RWRinse K Weersma
Rinse K Weersma

21 November 2010 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AFAndre Franke
Andre Franke
DMDermot P B McGovern
Dermot P B McGovern
JBJeffrey C Barrett
Jeffrey C Barrett
KWKai Wang
Kai Wang
GRGraham L Radford-Smith
Graham L Radford-Smith
MPMiles Parkes
Miles Parkes

29 June 2008 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
TCthe NIDDK IBD Genetics Consortium
the NIDDK IBD Genetics Consortium
JBJeffrey C Barrett
Jeffrey C Barrett
TCthe Belgian-French IBD Consortium
the Belgian-French IBD Consortium
TCthe Wellcome Trust Case Control Consortium
the Wellcome Trust Case Control Consortium
SHSarah Hansoul
Sarah Hansoul
MDMark J Daly
Mark J Daly